Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Obes Surg ; 28(5): 1277-1288, 2018 05.
Article in English | MEDLINE | ID: mdl-29103072

ABSTRACT

BACKGROUND: The effects of laparoscopic adjustable gastric band (LAGB) placement on upper gastrointestinal tract function in obese adolescents are unknown. Therefore, our aim was to determine the short-term effects of LAGB on esophageal motility, gastroesophageal reflux, gastric emptying, appetite-regulatory hormones, and perceptions of post-prandial hunger and fullness. METHODS: This study was part of a prospective cohort study (March 2009-December 2015) in one tertiary referral hospital. The study included obese adolescents (14-18 years) with a body mass index (BMI) > 40 (or ≥ 35 with comorbidities). Gastric emptying was assessed by 13C-octanoic acid breath test, pharyngeal, and esophageal motor function by high-resolution manometry with impedance (HRIM), and appetite and other perceptions using 100-mm visual analogue scales. Dysphagia symptoms were scored using a Dakkak questionnaire. Data were compared pre- and post-LAGB placement and at a 6-month follow-up. RESULTS: Based upon analysis of 15 adolescents, at the 6-month follow-up, LAGB placement: (i) led to a significant reduction in weight and BMI; (ii) increased fullness and decreased hunger post-meal; (iii) increased symptoms of dysphagia after solid food; and, despite these effects, (iv) caused little or no changes to appetite hormones, while (v) effects on gastric emptying, esophageal motility, esophageal bolus transport, and esophageal emptying were not significant. CONCLUSION: In adolescents, LAGB improved BMI and altered the sensitivity to nutrients without significant effects on upper gastrointestinal tract physiology at the 6-month follow-up.


Subject(s)
Gastroplasty , Obesity, Morbid/physiopathology , Obesity, Morbid/surgery , Pediatric Obesity/physiopathology , Pediatric Obesity/surgery , Upper Gastrointestinal Tract/physiology , Adolescent , Appetite Regulation/physiology , Bariatric Surgery/adverse effects , Bariatric Surgery/rehabilitation , Bariatric Surgery/statistics & numerical data , Body Mass Index , Case-Control Studies , Comorbidity , Female , Follow-Up Studies , Gastric Emptying , Gastroesophageal Reflux/epidemiology , Gastroesophageal Reflux/etiology , Gastroplasty/adverse effects , Gastroplasty/rehabilitation , Gastroplasty/statistics & numerical data , Humans , Laparoscopy/adverse effects , Laparoscopy/methods , Laparoscopy/statistics & numerical data , Male , Manometry , Morbidity , Obesity, Morbid/epidemiology , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Prospective Studies , Upper Gastrointestinal Tract/surgery , Weight Loss
2.
Int J Obes (Lond) ; 38(5): 636-42, 2014 May.
Article in English | MEDLINE | ID: mdl-23897220

ABSTRACT

BACKGROUND AND AIMS: Gastric vagal afferents convey satiety signals in response to mechanical stimuli. The sensitivity of these afferents is decreased in diet-induced obesity. Leptin, secreted from gastric epithelial cells, potentiates the response of vagal afferents to mechanical stimuli in lean mice, but has an inhibitory effect in high-fat diet (HFD)-induced obese mice. We sought to determine whether changes in vagal afferent function and response to leptin in obesity were reversible by returning obese mice consuming a HFD to standard laboratory chow diet (SLD). METHODS: Eight-week-old female C57BL/6 mice were either fed a SLD (N=20) or HFD (N=20) for 24 weeks. A third group was fed a HFD for 12 weeks and then a SLD for a further 12 weeks (RFD, N=18). An in vitro gastro-oesophageal vagal afferent preparation was used to determine the mechanosensitivity of gastric vagal afferents and the modulatory effect of leptin (0.1-10 nM) was examined. Retrograde tracing and quantitative RT-PCR were used to determine the expression of leptin receptor (LepR) messenger RNA (mRNA) in whole nodose and specific cell bodies traced from the stomach. RESULTS: After 24 weeks, both the HFD and RFD mice had increased body weight, gonadal fat mass, plasma leptin, plasma insulin and daily energy consumption compared with the SLD mice. The HFD and RFD mice had reduced tension receptor mechanosensitivity and leptin further inhibited responses to tension in HFD, RFD but not SLD mice. Mucosal receptors from both the SLD and RFD mice were potentiated by leptin, an effect not seen in HFD mice. LepR expression was unchanged in the whole nodose, but was reduced in the mucosal afferents of the HFD and RFD mice. CONCLUSION: Disruption of gastric vagal afferent function by HFD-induced obesity is only partially reversible by dietary change, which provides a potential mechanism preventing maintenance of weight loss.


Subject(s)
Gastric Mucosa/metabolism , Leptin/metabolism , Obesity/metabolism , Receptors, Leptin/metabolism , Thinness/metabolism , Vagus Nerve/metabolism , Afferent Pathways/metabolism , Animals , Body Weight , Diet, High-Fat , Energy Intake , Feeding Behavior , Female , Immunohistochemistry , Mice , Mice, Inbred C57BL , Real-Time Polymerase Chain Reaction , Weight Gain
3.
Scand J Gastroenterol ; 32(11): 1118-24, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9399392

ABSTRACT

BACKGROUND: Acute radiation-induced damage to the small bowel occurs frequently during abdominal radiotherapy. Since the small intestine is selectively responsive to the growth-promoting effects of insulin-like growth factor-I (IGF-I), we investigated the effects of IGF-I administration on mucosal recovery from radiation enteritis in the rat. METHODS: Rats received a single 10-Gy dose of total abdominal irradiation followed by implantation of mini-pumps infusing either IGF-I or vehicle for 4 days. After the rats had been killed, gut organs were weighed before light microscopic and biochemical examination. RESULTS: Irradiated rats receiving IGF-I lost less body weight than vehicle-treated rats, whereas the wet weights of the stomach, small intestine, and colon were increased by 10%, 19%, and 21%, respectively, and crypt depth was increased in the duodenum, jejunum, and ileum. CONCLUSIONS: IGF-I administration after abdominal irradiation increased small-intestinal mass and improved indicators of mucosal integrity, suggesting acceleration of small-intestinal mucosal recovery from radiation injury.


Subject(s)
Enteritis/drug therapy , Insulin-Like Growth Factor I/administration & dosage , Animals , Body Weight/drug effects , Body Weight/radiation effects , Colon/pathology , Disease Models, Animal , Duodenum/drug effects , Duodenum/radiation effects , Enteritis/etiology , Ileum/drug effects , Ileum/radiation effects , Insulin-Like Growth Factor I/therapeutic use , Intestinal Mucosa/drug effects , Intestinal Mucosa/radiation effects , Intestine, Small/pathology , Jejunum/drug effects , Jejunum/radiation effects , Male , Organ Size/drug effects , Organ Size/radiation effects , Radiation Injuries, Experimental/etiology , Radiation, Ionizing , Rats , Rats, Sprague-Dawley , Stomach/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...